Genome-Wide Epistatic Interaction between DEF1B and APOL1 High-Risk Genotypes for Chronic Kidney Disease.
暂无分享,去创建一个
A. Reiner | T. Matise | J. Coresh | C. Haiman | S. Buyske | R. Do | N. Franceschini | C. Kooperberg | R. Loos | G. Nadkarni | M. Graff | H. M. Vy | F. Thomas | O. Gutiérrez | B. Lin | C. Horowitz | P. Schnatz | R. Nassir | K. Campbell | F. Gulamali | Tanya S. Johns | R. Cooper | Jenny S. Wong | J. Coresh | H. Vy | R. Loos
[1] Stephanie A. Bien,et al. Genetic analyses of diverse populations improves discovery for complex traits , 2019, Nature.
[2] Christopher R. Gignoux,et al. Worldwide Frequencies of APOL1 Renal Risk Variants. , 2018, The New England journal of medicine.
[3] Nicholette D. Palmer,et al. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions. , 2018, Kidney international.
[4] George Hripcsak,et al. Development and validation of an electronic phenotyping algorithm for chronic kidney disease , 2014, AMIA.
[5] F. Marshall,et al. Cancer-Specific Loss of β-Defensin 1 in Renal and Prostatic Carcinomas , 2003, Laboratory Investigation.